| Region of Birth | ||||||
---|---|---|---|---|---|---|---|
Africa (Col %) | Southeast Asia (Col %) | Europe/Central Asia (Col %) | Latin America and the Caribbean (Col %) | South Asia (Col %) | Total (Col %) | p-value | |
Total | 353 (100) | 229 (100) | 303 (100) | 57 (100) | 2577 (100) | 3519 (100.0) | Â |
Hep B surface antigen | Â | Â | Â | Â | Â | 0.175 | |
 Non-reactive | 341 (98.8) | 206 (100) | 245 (99.6) | 50 (100) | 2151 (99.7) | 2993 (99.6) |  |
 Reactive | 4 (1.2) | 0 (0) | 1 (0.4) | 0 (0) | 7 (0.3) | 12 (0.4) |  |
Hep C | Â | Â | Â | Â | Â | Â | 0.818 |
 Non-reactive | 285 (99.3) | 87 (98.9) | 136 (100) | 36 (100) | 1519 (99.4) | 2063 (99.4) |  |
 Reactive | 2 (0.7) | 1 (1.1) | 0 (0) | 0 (0) | 9 (0.6) | 12 (0.6) |  |
HIV | Â | Â | Â | Â | Â | Â | 0.547 |
 Negative | 303 (99.7) | 190 (100) | 222 (100) | 50 (100) | 1883 (99.9) | 2648 (99.9) |  |
 Positive | 1 (0.3) | 0 (0) | 0 (0) | 0 (0) | 1 (0.1) | 2 (0.1) |  |
Female genital cutting | Â | Â | Â | Â | Â | 0.000 | |
 No | 223 (94.5) | 104 (100) | 218 (100) | 34 (100) | 1713 (99.9) | 2292 (99.4) |  |
 Yes | 13 (5.5) | 0 (0) | 0 (0) | 0 (0) | 1 (0.1) | 14 (0.6) |  |
Syphilis VDRL or RPR | Â | Â | Â | Â | Â | 0.796 | |
 Non-reactive | 92 (100) | 105 (99.1) | 62 (100) | 29 (100) | 545 (99.6) | 833 (99.6) |  |
 Reactive | 0 (0) | 1 (0.9) | 0 (0) | 0 (0) | 2 (0.4) | 3 (0.4) |  |